Athos Capital’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-342,871
Closed -$3.72M 46
2023
Q3
$3.72M Sell
342,871
-57,129
-14% -$613K 1.91% 17
2023
Q2
$4.27K Hold
400,000
3.33% 10
2023
Q1
$4.2M Hold
400,000
2.89% 11
2022
Q4
$4.1M Buy
+400,000
New +$4.06M 2.37% 7

Other funds holding RENE

Athos Capital's RENE Position: Q4 2023 in Review

Athos Capital sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 342,871 shares — an estimated $3.72M sold.

Athos Capital first reported a position in RENE in Q4 2022 and held it in 4 quarters. The position peaked at $4.2M in Q1 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • Athos Capital reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • Athos Capital sold 342,871 Cartesian Growth Corp II shares in Q4 2023, an estimated $3.72M.
  • Athos Capital first reported a position in Cartesian Growth Corp II in Q4 2022 and held it in 4 quarters.
  • Athos Capital's Cartesian Growth Corp II position peaked at $4.2M in Q1 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on Athos Capital's 13F filing for Q4 2023, filed 14 Feb 2024.